Table 1. Patient demographics.
|
Sydney cohort |
Vienna cohort |
Pleural effusion cohort |
||||
|---|---|---|---|---|---|---|
| MPM (N=37) | Non-MPM (N=32) | MPM (N=47) | Non-MPM (N=24) | MPM (N=30) | Non-MPM (N=60) | |
| Median age (range) | 71.4 (40–83) | 66.3 (49–80) | 64 (33–81) | 66.5 (56–82) | 76 (55–94) | 73.5 (49–96) |
|
Gender | ||||||
| Male | 32 (86.5%) | 27 (84.4%) | 35 (74.5%) | 19 (79.2%) | 26 (86.7%) | 51 (85%) |
| Female | 5 (13.5%) | 5 (15.6%) | 12 (25.5%) | 5 (20.8%) | 4 (13.3%) | 9 (15%) |
|
Diagnosis | ||||||
| MPM | 37 (100%) | 47 (100%) | 30 (100%) | |||
| Pleural Plaques/Pleuritis | 5 (15.6%) | 10 (41.7%) | 30 (50%) | |||
| Adenocarcinoma | ||||||
| Lung | 4 (16.7%) | 27 (45%) | ||||
| Breast | 1 (1.6%) | |||||
| Endometrial | 1 (1.6%) | |||||
| Colon | 1 (1.6%) | |||||
| Other lung cancer | 3 (12.5%) | |||||
| CAD | 27 (84.4%) | 7 (29.2%) | ||||
|
MPM histotype | ||||||
| Epithelioid | 26 (70.3%) | 35 (74.5%) | 27 (90%) | |||
| Biphasic | 8 (21.6%) | 7 (14.9%) | 2 (6.7%) | |||
| Sarcomatoid | 2 (5.4%) | 4 (8.5%) | 1 (3.3%) | |||
| Desmoplastic | 1 (2.7%) | 1 (2.1%) | 0 | |||
Abbreviations: CAD=coronary artery disease; MPM=malignant pleural mesothelioma.